FIMI is the leading private equity firm in Israel with more than $2 billion in assets under management. Since its founding by Ishay Davidi in 1996, FIMI has successfully completed 78 investments, executed 48 exits, and raised five funds. By both local and global standards, FIMI’s performance is exceptional. Preqin, the alternative assets industry’s leading source of data and intelligence, ranks FIMI as one of the top funds worldwide in terms of long-term return for investors. FIMI uses its knowledge, experience and resources to invest wisely, create value in its portfolio companies and generate maximum returns for FIMI investors. FIMI leverages a solid, proven, clear investment strategy, unrivaled access to quality deal-flow, and exceptional in-house expertise to achieve superior results.
Gal-Shvav Group is a privately-owned company specializing in the design, development, manufacturing, and assembly of optomechanical components and motion control systems. The company provides precision machining services for various sectors, including medical, military, semiconductor, printing, solar, and security industries. Gal-Shvav Group offers comprehensive technological solutions and logistical support throughout the entire product lifecycle, from initial concept to final delivery. With over three decades of experience, the company has established a strong reputation both in Israel and internationally, continually seeking innovative talent to drive professional growth and customer satisfaction.
EMET Computing is a full-service solution provider specializing in Data-Center, Cloud and Information Technologies. Founded in 1984, EMET accumulated extensive knowledge and partnership in the entire stack of infrastructure technology. EMET Computing is a public company, traded on the Tel-Aviv stock exchange. With offices in Ramat-Gan, Rosh-Ha’ayin, Petach-Tikva, Haifa and Ashdod, worldwide distribution hubs and a workforce of 850, EMET Computing can meet the most demanding customer challenges. Their experts match the best architecture to their customer challenges, propose and deploy best of breed solutions accompanied by class-leading services by highly trained professionals
Rafa Laboratories Ltd. is a pharmaceutical company based in Jerusalem, Israel, founded in 1937. It specializes in the manufacture, marketing, and distribution of prescription and over-the-counter medicines, as well as generic drugs and therapeutic products. As a prominent healthcare provider in Israel, Rafa Laboratories is dedicated to enhancing the health and quality of life of its consumers. The company operates in compliance with both Israeli and international ethical standards, adhering to local regulations governing drug manufacturing, distribution, marketing, and sales.
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. Kamada's product line consists of more than 10 injectable pharmaceutical products which are marketed in more than 15 countries worldwide. The Company's pharmaceuticals are produced in its state-of-the-art, cGMP-compliant, FDA-approved, large scale production facility. Kamada’s flagship product is Glassia®; an FDA approved intravenous (IV) Alpha-1 Antitrypsin (AAT) protein, for the treatment of AAT Deficiency. Glassia® is a high purity, ready to use and stabilizer free augmentation treatment. Kamada has a strategic agreement with Baxter for US marketing, distribution and licensing of Glassia®. Kamada’s second generation AAT product is an inhaled (IH) version. This product is already in advanced stages of clinical development for the treatment of AAT Deficiency. Other potential indications for AAT (IV or IH) include bronchiectasis, cystic fibrosis, COPD as well as type-1 diabetes for which the Company started a clinical trial. In addition to its capabilities to manufacture specialty proteins, Kamada has developed a platform technology for the production of specific immunoglobulins (IgGs). Kamada's unique know-how and capabilities enable it to seek new business opportunities and offer a wide scope of pharma-oriented services, including: R&D of new biopharmaceuticals, large scale production of high quality biopharmaceuticals, formulation and aseptic filling, registration and marketing. Over the years Kamada has established its presence in the pharma industry worldwide. Kamada’s mission is to develop, manufacture and provide high quality, specialty pharmaceuticals to patients, in order to support better quality of life and save lives.
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. Kamada's product line consists of more than 10 injectable pharmaceutical products which are marketed in more than 15 countries worldwide. The Company's pharmaceuticals are produced in its state-of-the-art, cGMP-compliant, FDA-approved, large scale production facility. Kamada’s flagship product is Glassia®; an FDA approved intravenous (IV) Alpha-1 Antitrypsin (AAT) protein, for the treatment of AAT Deficiency. Glassia® is a high purity, ready to use and stabilizer free augmentation treatment. Kamada has a strategic agreement with Baxter for US marketing, distribution and licensing of Glassia®. Kamada’s second generation AAT product is an inhaled (IH) version. This product is already in advanced stages of clinical development for the treatment of AAT Deficiency. Other potential indications for AAT (IV or IH) include bronchiectasis, cystic fibrosis, COPD as well as type-1 diabetes for which the Company started a clinical trial. In addition to its capabilities to manufacture specialty proteins, Kamada has developed a platform technology for the production of specific immunoglobulins (IgGs). Kamada's unique know-how and capabilities enable it to seek new business opportunities and offer a wide scope of pharma-oriented services, including: R&D of new biopharmaceuticals, large scale production of high quality biopharmaceuticals, formulation and aseptic filling, registration and marketing. Over the years Kamada has established its presence in the pharma industry worldwide. Kamada’s mission is to develop, manufacture and provide high quality, specialty pharmaceuticals to patients, in order to support better quality of life and save lives.
Plastopil develops, manufactures and markets an extensive array of flexible barrier films and technologically advanced packaging solutions that optimize the shelf-life and presentation of chilled foods. Over five decades, Plastopil has gained vast market experience, technological expertise, and a worldwide reputation for quality, integrity and service.
Bird Aerosystems Ltd develops and markets airborne missile protection systems, airborne surveillance products, and information and observation solutions. It also provides aviation logistics services to commercial and governmental customers; installation design and certification services; and scheduled and unscheduled maintenance for narrow-body aircraft. The company was founded in 2001 and is based in Herzliya, Israel.
PCB Technologies Ltd. is a one-stop solution fabrication of high reliability, multilayer Printed Circuit Boards and top level assemblies (PCBA). Since 1981 They provide wide range of manufacturing solutions that meet the highest industry standards. Their focus is serving highly demanding markets such as: Defense, Aerospace, Medical, RF/Microwave, Telecom and more. Their highly-experienced staff, state-of-the-art technologies and advanced processes help deliver innovative solutions and ensure cost-effective fabrication of the most challenging and complex boards. PCB Technologies is a subsidiary of PriorTech Group and is traded on the Tel-Aviv Stock Exchange (symbol. PCBT). The company currently occupies 17,000 square meter in an advanced manufcaturing facility and employs a staff of 700 with an annual turnover of around $100 million. PCB Technologies' one-stop-shop for CEM services – from design to complete production, including full turnkey capabilities.
Aitech Defense Systems, Inc. specializes in providing rugged embedded computing solutions for military, defense, and space applications globally. Founded in 1983 and headquartered in Chatsworth, California, the company has established a strong reputation for its innovative products, including power supplies, single board computers, Ethernet switches, and rugged enclosures. Aitech has pioneered the development of advanced commercial off-the-shelf (COTS) products that meet stringent military specifications, including boards capable of operating in extreme temperatures and environments. The company also offers system integration and technical support services, catering to high-profile projects in defense and space sectors. With additional operations in India, Aitech continues to expand its capabilities and product offerings to address the evolving needs of its customers.
Orbit Communication Systems Ltd. is an Israeli company that specializes in developing, manufacturing, and supplying communication equipment and solutions for airborne, maritime, and ground applications. Founded in 1950 and headquartered in Netanya, Orbit has over 60 years of experience in the industry, making it a prominent provider of satellite communication systems, tracking and telemetry systems, and communication management solutions. The company's offerings include mobile satellite communication products for marine, aerial, rail, and land use, as well as telemetry systems for missile tracking and airborne platforms. Orbit also provides advanced ground station solutions for Earth observation and remote sensing, focusing on tracking low Earth orbit (LEO) and medium Earth orbit (MEO) satellites. Its diverse range of clients includes commercial, private, and military organizations that rely on Orbit's technology for mission-critical communication needs, even in challenging environments.
G4S Israel
Acquisition in 2016
G4S Israel (formerly Hashmira) is a security company employs about 7,500 people and its annual sales turnover is estimated at NIS 800 million with an EBITDA margin of about 10%. The company's CEO, Micky Adiv, who has been in the position since 2006, is expected to remain together with the rest of the senior management. The company is part of the global G4S group which, according to its website, operates in over 100 countries and employs more than 610,000 people.
Ginegar Plastic Products, which produces and markets polyethylene sheets and nets for a variety of uses in agriculture and industry. Ginegar Plastic Products is a producer of advanced films for a wide variety of agricultural applications, with special emphasis on greenhouse covers, mulches, VIF films and also a range of non-agricultural applications.
eZoneXchange.com, a subsidiary of Sapiens International Corporation N.V., provides software solutions to market-makers of B2B e-marketplaces. eZoneXchange.com's mission is to help these e-marketplace makers integrate their IT systems with the IT systems of their customers and suppliers. eZoneXchange.com also offers end-to-end shipment management solutions for e-marketplace transactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.